Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
Retained Earnings
Aridis Pharmaceuticals Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
|
Retained Earnings
-$195.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Retained Earnings
-$2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Retained Earnings
$10.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
Amgen Inc
NASDAQ:AMGN
|
Retained Earnings
-$27.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-15%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Retained Earnings
$11.2B
|
CAGR 3-Years
95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Retained Earnings
$28B
|
CAGR 3-Years
33%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
See Also
What is Aridis Pharmaceuticals Inc's Retained Earnings?
Retained Earnings
-195.7m
USD
Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Retained Earnings amounts to -195.7m USD.
What is Aridis Pharmaceuticals Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-33%
Over the last year, the Retained Earnings growth was -18%. The average annual Retained Earnings growth rates for Aridis Pharmaceuticals Inc have been -25% over the past three years , -33% over the past five years .